Business Wire

NIQ’s 2026 Consumer Outlook: Bold Brands Win with Cautious Consumers

29.9.2025 15:00:00 CEST | Business Wire | Press Release

Share

NielsenIQ (NIQ) (NYSE: NIQ) today released its Consumer Outlook: Guide to 2026. This annual report is a strategic roadmap for driving growth in a volatile, fast-moving market where caution is the consumer’s default—highlighting opportunities for brands that pivot with purpose, build trust, and connect with consumers across channels.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250929977209/en/

The report indicates that consumers have adapted to constant change. While more people report feeling “confident,” this sentiment masks reality: Inflation, everyday expenses, and borrowing costs continue to squeeze wallets. In fact, 40% of global consumers say they're being cautious even as inflation cools.

The report also shows that today’s consumers are spending intentionally, rewarding retailers and brands that deliver trust, personalization, and convenience. Clean label products in the U.S. are growing at a rate of +7.5% this year, compared to the +5.9% overall U.S. FMCG average, proving that transparency and simplicity drive loyalty. Trust is now a key differentiator, with 95% of consumers saying that trust is critical when choosing a brand.

Inflation remains a global consumer concern, especially around rising food prices and a potential economic downturn. In addition, commodity volatility is adding pressure to brands. Coffee prices increased 26.9% between 2024 and 2025 while cocoa prices increased 127.9% between 2023 and 2024.

“Growth for brands depends on volume—capturing trips and baskets through sharper product assortment, innovation, and private label offerings that stretch limited discretionary dollars further. Despite growing consumer caution, brands can win loyalty by building trust and offering value beyond price,” said Marta Cyhan-Bowles, Chief Communications Officer & Head of Global Marketing COE at NIQ.

Seamless commerce is the next frontier. Consumers expect frictionless, personalized, and instant shopping pathways. In the US, in-store purchases lost 2.3% of occasions per buyer per year, while online occasions are up 16%. “Shoppers may discover a product on TikTok, compare it on Google, and buy it via WhatsApp. To win, brands must have an omnichannel strategy—from shelf to screen, from social to search,” Cyhan-Bowles added. “Success will come to companies that turn disruption—from health shifts to AI—into innovation, trust, and growth.”

NIQ’s Consumer Outlook report shows how these fast-moving disruptions demand proactive strategies. By bridging the gap between consumer intent and behavior, NIQ empowers brands to turn uncertainty into growth, trust, and innovation. Download the Consumer Outlook: Guide to 2026 report here.

About Consumer Outlook: Guide to 2026

NIQ’s Consumer Outlook: Guide to 2026 provides an analytic assessment of the state of consumers, based on a global footprint of consumer intelligence solutions and the feedback of nearly 19,000 consumers in 27 countries. The goal: to better understand their current thinking about the economic environment, as well as what they’re buying—and why. The survey was conducted between June 10 and July 8, 2025.

About NIQ

NielsenIQ (NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. Our global reach spans over 90 countries covering approximately 85% of the world’s population and more than $7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View. For more information, please visit www.niq.com.

© 2025 Nielsen Consumer LLC. All Rights Reserved.

Forward-Looking Statements Disclaimer

This press release may contain forward-looking statements regarding anticipated consumer behaviors, market trends, and industry developments. These statements reflect current expectations and projections based on available data, historical patterns, and various assumptions. Words such as “expects,” “anticipates,” “projects,” “believes,” “forecasts,” and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future outcomes and are subject to inherent uncertainties, including changes in consumer preferences, economic conditions, technological advancements, and competitive dynamics. Actual results may differ materially from those expressed or implied in these statements. While we strive to base our insights on reliable data and sound methodologies, we undertake no obligation to update any forward-looking statements to reflect future events or circumstances, except to the extent required by applicable law.

NIQ-GENERAL

View source version on businesswire.com: https://www.businesswire.com/news/home/20250929977209/en/

Contacts

Media Contact: media.relations@niq.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye